Our comprehensive background in medical publishing business development has allowed us to recognize gaps in what high level, ambitious marketing teams at pharma and biotech companies want to accomplish vs. what solutions publishers could offer. Integrated Medical Communications bridges that gap as our familiarity of this market is unparalleled.
Pharmaceutical, medical device and biotech companies have trusted and been beneficiaries of our ability to cultivate strong medical publishing relationships while developing cost-effective, strategic sales and marketing solutions. We listen to your strategic imperatives, create an integrated plan tailored to your needs and put that plan to work.
Joe Palumbo is the former Chief Operating Officer and partner of Digital Science Press, Inc., joining the leadership team in January 2016. During my tenure at DSP I co-founded the journal Everyday Urology - Oncology Insights and GUOncToday. I've spent my career focusing on serving my client's educational and promotional needs.
Meeting the unmet needs of physicians by offering quality content and resources in specific subsets of oncologic diseases rather than all conditions in the oncology sphere. New product approvals, conference highlights, incidence, disease presentation, clinical diagnosis, latest developments, new and emerging treatment options, and racial disparities are some of the physician led content being delivered, free of charge, in both print and digital formats.
This publication will feature exclusive content from The Leukemia & Lymphoma Society (LLS) providing content expertise relating to multiple myeloma.
Multiple Myeloma Today is a first-of-its-kind publication in the medical space that provides hematologists and oncologists content focused specifically on Myeloma, rather than all conditions in the oncology sphere.
The mission of Multiple Myeloma Today is to commit to advancement in hematology by providing essential editorial content to hematologists and oncologists in the United States. Multiple Myeloma Today achieves the articulated need of practicing physicians for practical, up-to-date clinical information in multiple myeloma (MM) through a comprehensive journal.
GU Oncology Now provides practical, timely, and relevant clinical information to practicing physicians treating genitourinary cancer within the United States. GU Oncology Now focuses on controversial topics and breaking news through expert analysis and key opinion leader interviews that offer in-depth viewpoints on clinical practice treatment.
Our vision is to create a high-quality, credible publication that is relevant, challenging, and thought provoking.